Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Food and Drug Administration (FDA) approval of BRINSUPRI (brensocatib 10 mg and 25 mg tablets), the first approved treatment for non-cystic fibrosis bronchiectasis (NCFB) in adults and children aged 12 and older
By: CNN Newsource July 24, 2026
While L-carnitine appears to have few possible side effects
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: two cases report
Undiagnosed thyroid issues are one of the most common reasons people can't lose weight
Important monitoring considerations during the initial months include regular follow-up with healthcare providers to assess tolerance, adjust dosing, and monitor for adverse effects
US$ 22.33
US$ 28.17
US$ 26.61
US$ 27.65
US$ 25.39
US$ 21.48
